|
1
|
Dzimiri N: Regulation of β-adrenoceptor
signaling in cardiac function and disease. Pharmacol Rev.
51:465–501. 1999.PubMed/NCBI
|
|
2
|
Xiao RP and Lakatta EG: Beta
1-adrenoceptor stimulation and beta 2-adrenoceptor stimulation
differ in their effects on contraction, cytosolic Ca2+,
and Ca2+ current in single rat ventricular cells. Circ
Res. 73:286–300. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng M, Han QD and Xiao RP: Distinct
β-adrenergic receptor subtype signaling in the heart and their
pathophysiological relevance. Sheng Li Xue Bao. 56:1–15.
2004.PubMed/NCBI
|
|
4
|
Bristow MR, Ginsburg R, Umans V, Fowler M,
Minobe W, Rasmussen R, Zera P, Menlove R, Shah P and Jamieson S:
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing
and failing human ventricular myocardium: coupling of both receptor
subtypes to muscle contraction and selective beta 1-receptor
down-regulation in heart failure. Circ Res. 59:297–309. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kiuchi K, Shannon RP, Komamura K, Cohen
DJ, Bianchi C, Homcy CJ, Vatner SF and Vatner DE: Myocardial
beta-adrenergic receptor function during the development of
pacing-induced heart failure. J Clin Invest. 91:907–914. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lv Z and Huang R: Common issues of
neuroendocrine antagonist in treatment of chronic cardiac failure.
Chin J Cardiol. 33:293–296. 2005.(In Chinese).
|
|
7
|
Aoyagi T, Yonekura K, Eto Y, Matsumoto A,
Yokoyama I, Sugiura S, Momomura S, Hirata Y, Baker DL and Periasamy
M: The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene
promoter activity is decreased in response to severe left
ventricular pressure-overload hypertrophy in rat hearts. J Mol Cell
Cardiol. 31:919–926. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kögler H, Hartmann O, Leineweber K, van
Nguyen P, Schott P, Brodde OE and Hasenfuss G: Mechanical
load-dependent regulation of gene expression in
monocrotaline-induced right ventricular hypertrophy in the rat.
Circ Res. 93:230–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dash R, Frank KF, Carr AN, Moravec CS and
Kranias EG: Gender influences on sarcoplasmic reticulum
Ca2+-handling in failing human myocardium. J Mol Cell
Cardiol. 33:1345–1353. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spragg DD, Leclercq C, Loghmani M, Faris
OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF and Kass DA:
Regional alterations in protein expression in the dyssynchronous
failing heart. Circulation. 108:929–932. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei J, Liu HC, Lee FY, Lee MS, Huang CY,
Pan HP and Lin CI: Role of the sarcoplasmic reticulum in altered
action potential and contraction of myopathic human and hamster
ventricle. Clin Exp Pharmacol Physiol. 30:232–241. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van de Caetsbeek I, Raeymaekers L, Wuytack
F and Vangheluwe P: Factors controlling the activity of the SERCA2a
pump in the normal and failing heart. Biofactors. 35:484–499. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sakata Y, Yamamoto K, Mano T, Nishikawa N,
Yoshida J, Nakayama H, Otsu K, Suzuki K, Tada M, Hori M, et al:
Angiotensin II type 1 receptor blockade prevents diastolic heart
failure through modulation of Ca(2+) regulatory proteins and
extracellular matrix. J Hypertens. 21:1737–1745. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sabbah HN, Sharov VG, Gupta RC, Mishra S,
Rastogi S, Undrovinas AI, Chaudhry PA, Todor A, Mishima T, Tanhehco
EJ, et al: Reversal of chronic molecular and cellular abnormalities
due to heart failure by passive mechanical ventricular containment.
Circ Res. 93:1095–1101. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chinese Society of Cardiology of Chinese
Medical Association, Editorial Board of Chinese Journal of
Cardiology: Guidelines for the diagnosis and management of chronic
heart failure. Chin J Cardiol. 35:1076–1095. 2007.
|
|
16
|
Brixius K, Frank KF, Bölck B, Hoyer F and
Schwinger RH: Reverse remodeling of the intracellular
Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of
heart failure. Wien Med Wochenschr. 156:209–215. 2006.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong H, Adamson DL, Ranu HK, Koch WJ,
Heubach JF, Ravens U, Zolk O and Harding SE: The effect of
Gi-protein inactivation on basal, and beta(1)- and
beta(2)AR-stimulated contraction of myocytes from transgenic mice
overexpressing the beta(2)-adrenoceptor. Br J Pharmacol.
131:594–600. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hamdani N, de Waard M, Messer AE, Boontje
NM, Kooij V, van Dijk S, Versteilen A, Lamberts R, Merkus D, Dos
Remedios C, et al: Myofilament dysfunction in cardiac disease from
mice to men. J Muscle Res Cell Motil. 29:189–201. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lohse MJ, Engelhardt S and Eschenhagen T:
What is the role of beta-adrenergic signaling in heart failure?
Circ Res. 93:896–906. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee DI, Vahebi S, Tocchetti CG, Barouch
LA, Solaro RJ, Takimoto E and Kass DA: PDE5A suppression of acute
beta-adrenergic activation requires modulation of myocyte beta-3
signaling coupled to PKG-mediated troponin I phosphorylation. Basic
Res Cardiol. 105:337–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tóth A, Kiss L, Varró A and Nánási PP:
Potential therapeutic effects of Na+/Ca2+
exchanger inhibition in cardiac diseases. Curr Med Chem.
16:3294–3321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vinge LE, Raake PW and Koch WJ: Gene
therapy in heart failure. Circ Res. 102:1458–1470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun H, Zhou F, Wang Y, Zhang Y, Chang A
and Chen Q: Effects of beta-adrenoceptors overexpression on cell
survival are mediated by Bax/Bcl-2 pathway in rat cardiac myocytes.
Pharmacology. 78:98–104. 2006. View Article : Google Scholar : PubMed/NCBI
|
